For press inquiries click here to contact us.
Press Release
Foresite Capital Raises $900M to Invest in Healthcare and Life Science Startups at All Stages
Press Release
Foresite Capital Strengthens Investor Relations and Business Development Teams with Addition of Hadi Tabbaa as Managing Director
Press Release
FSII and Pardes Biosciences Move Towards Merger With the Goal of Tackling COVID-19 via an Oral Antiviral for Treatment and Prevention of SARS-CoV-2 Infections
Press Release
Pardes Biosciences and FS Development Corp. II Announce Merger Agreement Creating Publicly Listed Biopharmaceutical Company Advancing Oral Antiviral Drugs to Treat and Prevent SARS-CoV-2 Infections
Press Release
Foresite Capital Raises $969 Million to Invest in Early to Late-Stage Companies Transforming Healthcare
Press Release
Alisa Mall Named As Managing Director at Foresite Capital
Press Release
FS Development Corp., Sponsored by Foresite Capital, Announces Pricing of Upsized $105 Million Initial Public Offering
Press Release
Michael Rome, PhD Promoted to Managing Director at Foresite Capital
Press Release
Foresite Capital Hires Nick Smith as Head of Investor Relations
Recognitions by unaffiliated third parties should not be construed as a current or past endorsement of Foresite Capital Management, LLC (“Foresite Capital”) or the private funds it manages. The rankings and recognitions published by Forbes are based on information prepared and submitted by Foresite Capital. Third party ratings are not representative of an individual investor’s investment results or the results of Foresite Capital and its funds. Past performance is no guarantee of future results. Please contact Foresite Capital for more detail on the criteria upon which the Forbes Midas List is based.
